Journals in Pharmacology
Journals in Pharmacology
- ISSN: 0165-6147
Trends in Pharmacological Sciences
Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that publishes reviews and opinions in fields broadly covering pharmacology, pharmacy, pharmaceutics and toxicology. Launched in 1979, TIPS every issue of TIPS contains succinct articles on the most exciting recent developments in pharmacology and therapeutics research. The major areas of research that TIPS is interested in are:Drug discovery and development (drug design, target identification and validation, lead generation, preclinical and clinical drug development, drug delivery, pharmaceutical formulation)Basic and clinical hharmacology (drug mechanisms, receptors, enzymes, ion channels, transporters, different classes of ligands, biomarkers, pharmacokinetics, pharmacodynamics, drug metabolism and pharmacogenetics)The... (gene- based, cell- based, protein-based therapy, other drug modalities, routes of administration, drug classes, drug nomenclature)Drug safety and toxicity (drug- drug interactions, adverse drug reactions, mechanisms of drug toxicity, pharmacovigilance)Ph... pharmacoepidemiology and pharmacoeconomicsTIP... particularly seeks articles that are relevant to one or more of these themes. Additionally, TIPS welcomes articles on biopharma regulatory landscape, science policy and regulation and bioethics.Reviews and opinions published in TIPS are usually invited by the editor, Dr. Kusumika Mukherjee but we welcome suggestions from the community as well. Please contact [email protected] for more information.Visit the Cell Press website for more information about Trends in Pharmacological Sciences - http://www.cell.com/...
- ISSN: 0378-8741
Journal of Ethnopharmacology
The Journal of Ethnopharmacology is the Official Journal of the International Society for Ethnopharmacology. The journal is dedicated to the exchange of information and understandings about people's use of plants, fungi, animals, microorganisms and minerals and their biological and pharmacological effects based on the principles established through international conventions.The Journal of Ethnopharmacology publishes original articles concerned with the observation and experimental investigation of the biological activities of plant and animal substances used in the traditional medicine of past and present cultures, which document indigenous medical knowledge, study indigenous medicines in order to contribute in the long-run to improved health care in the regions of study, and which report on pharmacologically unique principles from existing indigenous remedies.The journal will particularly welcome interdisciplinary papers with an ethnopharmacological... an ethnobotanical or an ethnochemical approach to the study of indigenous drugs. It is imperative that experimental studies are aligned and related to the traditional use(s).Furthermore:R... of anthropological and ethnobotanical field studies fall within the journal's scope.Studies involving pharmacological and toxicological mechanisms of action are especially welcome.Clinical studies on efficacy will be considered if contributing to the understanding of specific ethnopharmacological problems.The journal welcomes review articles in the above-mentioned fields especially those highlighting the multi-disciplinary nature of ethnopharmacology.
- ISSN: 1551-7144
Contemporary Clinical Trials
Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers not exceeding 4,000 words, short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/comment... on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.The following topics are covered in the journal:Unconvention... design features of specific trials and their rationalePreliminary or full results of clinical trials with unconventional design featuresStatistical methods for all aspects of clinical trialsMethodologies for clinical trial operations including trial management and optimization; patient recruitment and retention; and trial quality monitoring and assessmentData management methodologies including data collection; database maintenance; data quality assurance; safety monitoring and risk management; and patient registriesRegulatory requirements and their impact on clinical trialsEthical and legal considerations in clinical trialsRisk-benefit, cost-effectiveness and decision analyses in clinical trialsContemporary Clinical Trials is unique in that it is outside the confines of disease specifications, and it strives to adapt and grow with an expanding clinical trials landscape as the needs of clinical research evolve in today's dynamic healthcare environment.Having taken upon the important role as a platform for knowledge exchange between experts in different disciplines related to clinical trials, the ultimate goal of Contemporary Clinical Trials is to advance this field of research for the benefit of patients.We look forward to receiving your contribution! Authors are also welcome to submit to the journal's open access companion title, Contemporary Clinical Trials Communications .Benefits to authors Contemporary Clinical Trials also provides many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
- ISSN: 0006-2952
Biochemical Pharmacology
Biochemical Pharmacology publishes original research findings and review articles related to the elucidation of cellular and tissue function(s) at the biochemical and molecular levels, the modification of cellular phenotype(s) by genetic, transcriptional/tran... or drug/compound-induce... modifications, as well as the pharmacodynamics and pharmacokinetics of xenobiotics and drugs, the latter including both small molecules and biologics.The journal's target audience includes scientists engaged in the identification and study of the mechanisms of action of xenobiotics, biologics and drugs and in the drug discovery and development process.All areas of cellular biology and cellular, tissue/organ and whole animal pharmacology fall within the scope of the journal. Drug classes covered include anti-infectives, anti-inflammatory agents, chemotherapeutics, cardiovascular, endocrinological, immunological, metabolic, neurological and psychiatric drugs, as well as research on drug metabolism and kinetics. While medicinal chemistry is a topic of complementary interest, manuscripts in this area must contain sufficient biological data to characterize pharmacologically the compounds reported. Submissions describing work focused predominately on chemical synthesis and molecular modeling will not be considered for review.While particular emphasis is placed on reporting the results of molecular and biochemical studies, research involving the use of tissue and animal models of human pathophysiology and toxicology is of interest to the extent that it helps define drug mechanisms of action, safety and efficacy.Reports describing experiments conducted with natural product mixtures, plant or animal extracts will not be considered for publication unless the structures and concentrations of all component substances are known, and the agents can be easily obtained by others wishing to replicate the study.The chemical structure of all novel compounds tested must be included in the submitted manuscript or be readily accessible in the published literature. References to structures in the patent literature must unambiguously identify a single molecular structure. All compounds, reagents, instrumentation and equipment employed in a study must be available from identified commercial suppliers, bio/pharmaceutical companies or from individuals holding legal rights to their use. Submissions will not be considered for publication if the chemical structures of tested compounds are not revealed, generally known, or accessible in the literature.Original research submissions must contain:A rationale for the selection of the compound/drug for study as well as for the concentrations/doses employed. Quantities used for concentration- and dose-response experiments should vary logarithmically, e.g., 1, 3, 10, 30 mg/kg, 0.1, 1.0, 10, 100 nanomolar, etc. Justification must be provided for studying only a single concentration or dose of a compound, especially as it relates to reference standards and antagonists/modulato... of receptors, enzymes and signaling pathways.Justificati... must also be provided for the selection of the statistical tests employed as they relate to the experimental design.It is expected that all findings have been subjected to rigorous quantitative analyses, with the calculation and reporting of IC50, Ki, EC50, etc., values. These must be derived from a minimum of three (3) separate and distinct experiments, with the replicates within any single experiment being averaged to obtain a single value for that experimental series.Manuscripts that fail to meet these criteria will be subject to rejection without peer-review.
- ISSN: 0920-9964
Schizophrenia Research
An International Multidisciplinary Journal of the Schizophrenia International Research SocietyAs an official journal of the Schizophrenia International Research Society (SIRS) Schizophrenia Research is THE journal of choice for international researchers and clinicians to share their work with the global schizophrenia research community. More than 6000 institutes have online or print (or both) access to this journal - the largest specialist journal in the field, with the largest readership!Schizophr... Research's time to first decision is as fast as 6 weeks and its publishing speed is as fast as 4 weeks until online publication (corrected proof/Article in Press) after acceptance and 14 weeks from acceptance until publication in a printed issue.The journal publishes novel papers that really contribute to understanding the biology and treatment of schizophrenic disorders; Schizophrenia Research brings together biological, clinical and psychological research in order to stimulate the synthesis of findings from all disciplines involved in improving patient outcomes in schizophrenia.Manusc... with a focus on cognition in schizophrenia can be submitted to the journal's open access companion title, Schizophrenia Research: Cognition.
- ISSN: 0168-3659
Journal of Controlled Release
The Journal of Controlled Release (JCR) is the Official Journal of the Controlled Release Society, and of the Japan Society of Drug Delivery System.It publishes high-quality research articles in the broad field of delivery science and technology. This includes drug delivery systems and all aspects of formulations, such as physicochemical and biological properties of drugs, design and characterization of dosage forms, release mechanisms, in vivo testing, and formulation research and development in the disciplines of pharmaceutical, diagnostic, agricultural, environmental, cosmetic, and food industries.Manuscrip... that advance fundamental understanding of principles and/or demonstrate advantages of novel technologies in safety and efficacy over current clinical standards will be given priority.
- ISSN: 0306-4522
Neuroscience
Neuroscience is the official journal of the International Brain Research Organization (IBRO). Founded in 1976, Neuroscience is IBRO’s flagship journal and its profits support IBRO's numerous international initiatives for investigators at all career stages and the neuroscience community worldwide. Neuroscience publishes high-quality peer-reviewed articles on fundamental science, meta-analyses, clinical studies, and reviews focused on the scientific study of the central, peripheral, and enteric nervous systems. As an international, interdisciplinary journal, Neuroscience covers research in molecular, cellular, developmental, systems, behavioural, cognitive and computational neuroscience.Neurosc... and IBRO are committed to promoting diversity, equity, and inclusion in all aspects of the journal. We strongly encourage consideration of diversity in authorship teams and article references. Additionally, we require robust justification for the choice of sex and gender in cellular and animal models, as well as in patient inclusion/exclusion criteria in clinical trials or sample collection. Research areas include, but are not limited to:The central, peripheral, and enteric nervous systems, including neuroscience related to the brain, retina, spinal cord, and gut-brain axis.The neuroscience of physiological processes encompassing all life stages (development, adulthood, aging) and related to multiple conditions, including infection, memory, neuroimmunology, pain, addiction, reward, stress, and synaptic plasticity.Neurologi... diseases and disorders, such as Alzheimer’s disease, autism spectrum disorder, deafness, mood disorders, epilepsy, Huntington’s disease, Parkinson’s disease and stroke.Neuroinflamma... including the role of microglia, astrocytes, and other non-neuronal nervous system cell types. Neuroscience related to the understanding of cognition, emotion, and behaviour. Neuroscience-related techniques and technologies, including artificial intelligence, computational neuroscience, electrophysiology, optogenetics, and neural imaging. Neuroscience-related therapeutics, including pharmaceutical interventions, exercise, nutrition, neuroscience reprogramming, stem cell therapy, transcranial magnetic stimulation. Reviews: We welcome unsolicited reviews that offer new insights, perspectives, or opinions on a controversy or innovation in the field. Reviews that merely reiterate background information will not be accepted. Mendelian Randomization: While recognizing its value to the field, Neuroscience does not accept papers that use Mendelian Randomization as its only technique. Studies utilising this technique need to also incorporate a neuroscience-specifi... hypothesis, mechanistic investigation, experimental manipulation and / or substantive insights into neural function, structure, disease mechanisms, or behavior.
- ISSN: 0891-5849
Free Radical Biology & Medicine
An official JOURNAL of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe; affiliate journal of the International Society for Free Radical Research (SFRRI)Free Radical Biology and Medicine is the premier forum for publishing ground-breaking research in the redox biology of both health and disease. We focus on signal transduction and redox signaling; oxidative stress; reductive stress; redox stress; nitrosative stress; aging and age-related diseases; redox biology in skeletal and cardiac muscle, exercise science, and sports medicine; metabolic regulation and metabolic diseases; mitochondrial function and signaling; homeostatic mechanisms and adaptive responses; redox chemistry and mechanisms; materials and nanomaterials; non-thermal plasmas; microorganisms, fungi, plants, insects, animals, and humans; and antioxidant enzymes, pathways, and networks. We welcome both full-length and short Research Communications, Hypothesis Papers, Reviews, Mini Reviews, Graphical Reviews, and Critical Methods Papers. Free Radical Biology and Medicine also commissions themed Special Issues aimed at highlighting recent advances in both basic and clinical fields, with a particular focus on mechanisms underlying altered metabolism and redox signalling.
- ISSN: 1471-4892
Current Opinion in Pharmacology
Current Opinion in Pharmacology (COPHAR) publishes authoritative, comprehensive, and systematic reviews. COPHAR helps specialists keep up to date with a clear and readable synthesis of current advances in pharmacology and drug discovery. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight into areas of importance.COPHAR is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Pharmacology and Drug Discovery (CRPHAR).COPHAR publishes the latest advancements in pharmacological sciences, covering, but not limited to, the following human systems:Cardiovascul... systemsDigestive and excretory systemsEndocrine systemImmune and lymphatic systemsMusculoskelet... systemNervous systemReproductive systemRespiratory systemUrinary and renal systemsAdditionally, COPHAR particularly welcomes submissions related to:CancerImmunomodul... disordersNeurologica... and psychiatric disordersEmerging technologiesGender and agingThe journal builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.Expertise - Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant.Comprehensi... - There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry.Impact - In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores.Discovera... Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast, global audience.Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors of the journal. They divide their section into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authorities on each topic that they have selected.Submissions... Opinion in Pharmacology allows two ways to submit to the journal:Invitation – in accordance with the established procedure for all Current Opinion titles, andNEW– authors are given a “spontaneous submission option” via the submission portal “General Pharmacology” at https://www.editoria... to open the journal to the authorship fully.Short Reviews Authors write short review articles in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the previous year.Editorial Overview Section Editors write a short overview at the beginning of the section to introduce the reviews and to draw the reader's attention to any particularly interesting developments.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it is useful to outline our expectations of authors and the procedures that the journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential; full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict.For more information, please refer to: https://www.elsevier...
- ISSN: 0014-2999
European Journal of Pharmacology
The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems.The scope includes: Behavioural pharmacology, Neuropharmacology and psychopharmacology, Cardiovascular pharmacology, Pulmonary, gastrointestinal and urogenital pharmacology, Endocrine pharmacology, Immunopharmacology and inflammation, Molecular and cellular pharmacology, Regenerative pharmacology, Biologicals and biotherapeutics, Translational pharmacology and Nutriceutical pharmacology.The journal publishes full-length papers and reviews. Ethnopharmacological studies with plant extracts or mixtures are not in scope of this journal.The table of contents for this journal is now available pre-publication, via e-mail, as part of the free ContentsDirect service from Elsevier. Please send an e-mail message to [email protected]... for further information about this service.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center